Swiss National Bank’s Kyntra Bio KYNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-7,792
| Closed | -$526K | – | 2611 |
|
|
2023
Q2 | $526K | Buy |
7,792
+88
| +1% | +$36.4K | ﹤0.01% | 2528 |
|
|
2023
Q1 | $3.59M | Sell |
7,704
-896
| -10% | -$474K | ﹤0.01% | 1465 |
|
|
2022
Q4 | $3.44M | Buy |
8,600
+192
| +2% | +$73.5K | ﹤0.01% | 1543 |
|
|
2022
Q3 | $2.73M | Buy |
8,408
+108
| +1% | +$34.8K | ﹤0.01% | 1658 |
|
|
2022
Q2 | $2.19M | Buy |
8,300
+408
| +5% | +$104K | ﹤0.01% | 1844 |
|
|
2022
Q1 | $2.37M | Buy |
7,892
+564
| +8% | +$197K | ﹤0.01% | 1936 |
|
|
2021
Q4 | $2.58M | Hold |
7,328
| – | – | ﹤0.01% | 1888 |
|
|
2021
Q3 | $1.87M | Buy |
7,328
+108
| +1% | +$38.3K | ﹤0.01% | 2098 |
|
|
2021
Q2 | $4.81M | Sell |
7,220
-264
| -4% | -$152K | ﹤0.01% | 1521 |
|
|
2021
Q1 | $6.49M | Buy |
7,484
+128
| +2% | +$136K | ﹤0.01% | 1294 |
|
|
2020
Q4 | $6.82M | Buy |
7,356
+84
| +1% | +$88.3K | ﹤0.01% | 1159 |
|
|
2020
Q3 | $7.48M | Buy |
7,272
+264
| +4% | +$284K | 0.01% | 950 |
|
|
2020
Q2 | $7.1M | Buy |
7,008
+916
| +15% | +$851K | 0.01% | 953 |
|
|
2020
Q1 | $5.29M | Buy |
6,092
+100
| +2% | +$99.4K | 0.01% | 907 |
|
|
2019
Q4 | $6.42M | Buy |
5,992
+156
| +3% | +$159K | 0.01% | 1003 |
|
|
2019
Q3 | $5.39M | Buy |
5,836
+104
| +2% | +$114K | 0.01% | 1047 |
|
|
2019
Q2 | $6.47M | Buy |
5,732
+156
| +3% | +$171K | 0.01% | 963 |
|
|
2019
Q1 | $7.58M | Buy |
5,576
+208
| +4% | +$282K | 0.01% | 857 |
|
|
2018
Q4 | $6.21M | Buy |
5,368
+124
| +2% | +$139K | 0.01% | 864 |
|
|
2018
Q3 | $7.96M | Buy |
5,244
+64
| +1% | +$98.6K | 0.01% | 834 |
|
|
2018
Q2 | $8.11M | Buy |
5,180
+328
| +7% | +$428K | 0.01% | 814 |
|
|
2018
Q1 | $5.6M | Buy |
4,852
+276
| +6% | +$363K | 0.01% | 979 |
|
|
2017
Q4 | $5.42M | Buy |
4,576
+72
| +2% | +$90.3K | 0.01% | 998 |
|
|
2017
Q3 | $6.06M | Buy |
4,504
+540
| +14% | +$569K | 0.01% | 910 |
|
|
2017
Q2 | $3.2M | Buy |
3,964
+660
| +20% | +$460K | ﹤0.01% | 1280 |
|
|
2017
Q1 | $2.04M | Buy |
3,304
+104
| +3% | +$63.3K | ﹤0.01% | 1549 |
|
|
2016
Q4 | $1.71M | Hold |
3,200
| – | – | ﹤0.01% | 1666 |
|
|
2016
Q3 | $1.66M | Hold |
3,200
| – | – | ﹤0.01% | 1633 |
|
|
2016
Q2 | $1.31M | Hold |
3,200
| – | – | ﹤0.01% | 1797 |
|
|
2016
Q1 | $1.64M | Buy |
3,200
+664
| +26% | +$331K | ﹤0.01% | 1573 |
|
|
2015
Q4 | $1.93M | Buy |
2,536
+44
| +2% | +$29.2K | ﹤0.01% | 1369 |
|
|
2015
Q3 | $1.37M | Buy |
2,492
+2,084
| +511% | +$1.26M | ﹤0.01% | 1570 |
|
|
2015
Q2 | $240K | Buy |
+408
| New | +$237K | ﹤0.01% | 2512 |
|
Other funds holding KYNB
AC
Swiss National Bank's KYNB Position: Q3 2023 in Review
Swiss National Bank sold out of Kyntra Bio (KYNB) in Q3 2023, closing a stake of 7,792 shares — an estimated $526K sold.
Swiss National Bank first reported a position in KYNB in Q2 2015 and held it in 33 quarters. The position peaked at $8.11M in Q2 2018. 110 funds tracked by Wall St. Rank hold KYNB as of Q3 2023.
- Swiss National Bank reported no remaining Kyntra Bio position as of Q3 2023 after selling out during the quarter.
- Swiss National Bank sold 7,792 Kyntra Bio shares in Q3 2023, an estimated $526K.
- Swiss National Bank first reported a position in Kyntra Bio in Q2 2015 and held it in 33 quarters.
- Swiss National Bank's Kyntra Bio position peaked at $8.11M in Q2 2018.
- 110 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2023.
Based on Swiss National Bank's 13F filing for Q3 2023, filed 8 Nov 2023.